Stay updated on Pemigatinib Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.

Latest updates to the Pemigatinib Dose-Escalation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, blocking access to the study record and related documents. This change changes the page’s usability by preventing access to its primary content.SummaryDifference25%

- Check20 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0. This represents a backend/template update and does not alter the study details shown on the page.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, indicating a newer build of the site; no substantive changes to the study details are reflected.SummaryDifference0.0%

- Check55 days agoChange DetectedPage revision tag updated from v3.6.4 to v3.6.5. This reflects a new page version without changing the substantive study content.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a minor version update to the page/system.SummaryDifference0.0%

- Check98 days agoChange DetectedThe page's revision indicator was updated from v3.6.0 to v3.6.3 in the footer, reflecting a version bump without altering the displayed study details.SummaryDifference0.0%

Stay in the know with updates to Pemigatinib Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.